Found: 19
Select item for more details and to access through your institution.
Risk factors for pulmonary cement embolism after percutaneous vertebroplasty and radiofrequency ablation for spinal metastases.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1129658
- By:
- Publication type:
- Article
Health-Related Quality of Life, Symptoms, and Tolerability of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 3, p. 158, doi. 10.1016/j.clml.2021.09.001
- By:
- Publication type:
- Article
ABCL-396: Incidence, Onset, and Management of Edema and Effusion in Patients Treated with Loncastuximab Tesirine for R/R DLBCL in the LOTIS Clinical Trial Program.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S397, doi. 10.1016/S2152-2650(21)01899-1
- By:
- Publication type:
- Article
ABCL-362: Incidence, Onset, and Management of Myelosuppression in Patients Treated with loncastuximab Tesirine for R/R DLBCL in a Pooled Safety Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S394, doi. 10.1016/S2152-2650(21)01894-2
- By:
- Publication type:
- Article
Poster: ABCL-396: Incidence, Onset, and Management of Edema and Effusion in Patients Treated with Loncastuximab Tesirine for R/R DLBCL in the LOTIS Clinical Trial Program.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S238, doi. 10.1016/S2152-2650(21)01498-1
- By:
- Publication type:
- Article
Poster: ABCL-362: Incidence, Onset, and Management of Myelosuppression in Patients Treated with loncastuximab Tesirine for R/R DLBCL in a Pooled Safety Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S238, doi. 10.1016/S2152-2650(21)01497-X
- By:
- Publication type:
- Article
CHARACTERIZATION AND MANAGEMENT OF CUTANEOUS REACTIONS IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH LONCASTUXIMAB TESIRINE IN THE LOTIS-2 TRIAL.
- Published in:
- Oncology Nursing Forum, 2022, v. 49, n. 2, p. E59, doi. 10.1188/22.ONF.E2
- By:
- Publication type:
- Article
Melanoma Molecular Subtypes and Development of Prognostic and Immunotherapy-Related Genetic Characteristics by Ferroptosis Gene Analysis.
- Published in:
- Computational & Mathematical Methods in Medicine, 2022, p. 1, doi. 10.1155/2022/2992939
- By:
- Publication type:
- Article
Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis.
- Published in:
- FASEB Journal, 2018, v. 32, p. 52, doi. 10.1096/fj.201700375R
- By:
- Publication type:
- Article
Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis.
- Published in:
- FASEB Journal, 2018, v. 32, n. 1, p. 52, doi. 10.1096/fj.201700375R
- By:
- Publication type:
- Article
Three-band triangular linearly frequency-modulated continuous-wave microwave photonic radar based on the gain-switched DFB laser.
- Published in:
- Optical & Quantum Electronics, 2024, v. 56, n. 7, p. 1, doi. 10.1007/s11082-024-07063-6
- By:
- Publication type:
- Article
Short Cyclic Regimen With Parathyroid Hormone (PTH) Results in Prolonged Anabolic Effect Relative to Continuous Treatment Followed by Discontinuation in Ovariectomized Rats.
- Published in:
- Journal of Bone & Mineral Research, 2022, v. 37, n. 4, p. 616, doi. 10.1002/jbmr.4495
- By:
- Publication type:
- Article
Plasminogen Regulates Fracture Repair by Promoting the Functions of Periosteal Mesenchymal Progenitors.
- Published in:
- Journal of Bone & Mineral Research, 2021, v. 36, n. 11, p. 2229, doi. 10.1002/jbmr.4423
- By:
- Publication type:
- Article
Gli1 Defines a Subset of Fibro‐adipogenic Progenitors that Promote Skeletal Muscle Regeneration With Less Fat Accumulation.
- Published in:
- Journal of Bone & Mineral Research, 2021, v. 36, n. 6, p. 1159, doi. 10.1002/jbmr.4265
- By:
- Publication type:
- Article
Periosteal Mesenchymal Progenitor Dysfunction and Extraskeletally‐Derived Fibrosis Contribute to Atrophic Fracture Nonunion.
- Published in:
- Journal of Bone & Mineral Research, 2019, v. 34, n. 3, p. 520, doi. 10.1002/jbmr.3626
- By:
- Publication type:
- Article
Activin A marks a novel progenitor cell population during fracture healing and reveals a therapeutic strategy.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.89822
- By:
- Publication type:
- Article
Estimation of reliability in a three-factor model.
- Published in:
- Statistics in Medicine, 2011, v. 30, n. 11, p. 1254, doi. 10.1002/sim.4182
- By:
- Publication type:
- Article
Loading‐Induced Reduction in Sclerostin as a Mechanism of Subchondral Bone Plate Sclerosis in Mouse Knee Joints During Late‐Stage Osteoarthritis.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 2, p. 230, doi. 10.1002/art.40351
- By:
- Publication type:
- Article
MiR-21 participates in LPS-induced myocardial injury by targeting Bcl-2 and CDK6.
- Published in:
- Inflammation Research, 2022, v. 71, n. 2, p. 205, doi. 10.1007/s00011-021-01535-1
- By:
- Publication type:
- Article